Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
B large-cell lymphoma in children and adolescents.
Raetz E, Perkins S, Davenport V, Cairo MS. Raetz E, et al. Among authors: davenport v. Cancer Treat Rev. 2003 Apr;29(2):91-8. doi: 10.1016/s0305-7372(02)00108-1. Cancer Treat Rev. 2003. PMID: 12670451 Review.
Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group.
Miles RR, Raphael M, McCarthy K, Wotherspoon A, Lones MA, Terrier-Lacombe MJ, Patte C, Gerrard M, Auperin A, Sposto R, Davenport V, Cairo MS, Perkins SL; SFOP/LMB96/CCG5961/UKCCSG/NHL 9600 Study Group. Miles RR, et al. Among authors: davenport v. Pediatr Blood Cancer. 2008 Sep;51(3):369-74. doi: 10.1002/pbc.21619. Pediatr Blood Cancer. 2008. PMID: 18493992 Free PMC article.
Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study.
Cairo MS, Davenport V, Bessmertny O, Goldman SC, Berg SL, Kreissman SG, Laver J, Shen V, Secola R, van de Ven C, Reaman GH. Cairo MS, et al. Among authors: davenport v. Br J Haematol. 2005 Jan;128(1):49-58. doi: 10.1111/j.1365-2141.2004.05281.x. Br J Haematol. 2005. PMID: 15606549 Free article. Clinical Trial.
Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A children's oncology group study report.
Satwani P, Sather H, Ozkaynak F, Heerema NA, Schultz KR, Sanders J, Kersey J, Davenport V, Trigg M, Cairo MS. Satwani P, et al. Among authors: davenport v. Biol Blood Marrow Transplant. 2007 Feb;13(2):218-27. doi: 10.1016/j.bbmt.2006.09.013. Biol Blood Marrow Transplant. 2007. PMID: 17241927 Free PMC article. Clinical Trial.
Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience.
Van Winkle P, Angiolillo A, Krailo M, Cheung YK, Anderson B, Davenport V, Reaman G, Cairo MS. Van Winkle P, et al. Among authors: davenport v. Pediatr Blood Cancer. 2005 Apr;44(4):338-47. doi: 10.1002/pbc.20227. Pediatr Blood Cancer. 2005. PMID: 15503297 Clinical Trial.
Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC).
Houtenbos I, Bracho F, Davenport V, Slack R, van de Ven C, Suen Y, Killen R, Shen V, Cairo MS. Houtenbos I, et al. Among authors: davenport v. Bone Marrow Transplant. 2001 Jan;27(2):145-53. doi: 10.1038/sj.bmt.1702750. Bone Marrow Transplant. 2001. PMID: 11281383 Clinical Trial.
48 results